SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH L impact

Royalty Pharma Posts Q3 Net Income of $145M

RPRX
SquawkNews Desk 2 updates Updated Nov 04, 2026, 12:24 PM UTC

Story updates

12:18:02 PM UTC
SquawkNews
07:17 AM EST, 11/04/2026 (MT Newswires) -- Royalty Pharma (RPRX) reported Q3 attributable net income
12:24:08 PM UTC
SquawkNews
Royalty Pharma Q3 2026 attributable net income falls 49% year over year to $145 million Royalty

Related stories

Neuronetics Reports Q3 Gross Margin of 52.2% M impact | EARNINGS | Nov 04, 2026, 12:52 PM UTC Peabody Sees Q4 U.S. Thermal PRB Volume at 19.5–21.5 Million Tons Peabody sees Q4 U.S. thermal PRB volume of 19.5–21.5 million tons at an average price of $13.75 per ton. M impact | EARNINGS | Nov 04, 2026, 12:51 PM UTC Neuronetics Sees 2026 Revenue of $160M-$164M M impact | EARNINGS | Nov 04, 2026, 12:51 PM UTC Peabody Sees Q4 Seaborne Thermal Volume at 3.6–3.8 Million Tons Peabody expects Q4 seaborne metallurgical coal volume of 2.2–2.4 million tons. M impact | EARNINGS | Nov 04, 2026, 12:50 PM UTC McDonald’s Reports First U.S. Sales Decline in Six Quarters in Q3 L impact | EARNINGS | Nov 04, 2026, 12:50 PM UTC NeuroNetics Reports Q3 EPS of USD -0.02 L impact | EARNINGS | Nov 04, 2026, 12:50 PM UTC